Product Code: PM2563
The global Animal Biotechnology Market size is expected to reach USD 48.95 billion by 2030, according to a new study by Polaris Market Research. The report "Animal Biotechnology Market Share, Size, Trends, Industry Analysis Report, By Animal Type; By Product Type (Drugs, Diagnostic Test, Vaccinations, Feed Additives, Reproductive and Genetic); By Application; By End-Use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides an analysis of future market growth.
Factors such as the strategic development of industry players, including product innovations and collaboration to extend their product lines, the prevalence of the animal disease, as well as increasing demand for vaccines, drugs, diagnostic tests, and other animal biotechnology products are responsible for driving the growth of the industry.
All over the globe, animal feed, vaccinations, and diagnostics for diseases including salmonella, foot-and-mouth disease, and bovine spongiform encephalopathy (BSE) have all been enhanced via biotechnology. National animal disease control programs were also scaled back or even suspended globally. Additionally, higher regulatory approvals and increased R&D activity by prominent industry players are anticipated to drive industry expansion during the upcoming period.
The outbreak of the COVID-19 pandemic has impacted the industry. Due to the surge in COVID-19 cases, many economies across the globe allowed only emergency or urgent procedures for veterinary healthcare. In addition, veterinary visits and diagnostic procedures were delayed, and demand for animal biotechnology products rebounded.
Animal Biotechnology Market Report Highlights
Livestock segment accounted for the largest revenue share in 2021 owing to the rising importance of livestock is increasing for developing agriculture in emerging countries. In many countries, livestock now makes up a more significant portion of agriculture and the GDP.
The demand for products made from animals is very great worldwide. This biotechnology market sector's expansion is fueled by factors such as an increase in the urban population, dietary and lifestyle changes, and higher cattle production. Government vaccination campaigns for cattle also encourage market growth.
The rise of the animal vaccination market is due to the increasing incidence of animal diseases. These conditions naturally spread from animals to people.
The preventive care of animal segment accounted for the highest revenue share in 2021 and is expected to expand the adaptability of companion animals.
Globalization and climate change are responsible for rising in zoonotic illness. As a result of this, veterinary hospitals and clinics generated the highest revenue share in 2021
In 2021 North America has generated the largest market share in market. The growth of the market in this region is due to the increasing the demand for animal-based products, rising pet adaptation, and advancement in veterinary healthcare infrastructure.
Major players operating in the industry are Bayer AG, Boehringer Ingelheim International GmbH, Biogenesis Bago, Ceva, CSL Limited, Elanco, Heska Corporation, Hester Biosciences Limited, Idexx Laboratories, Id Vet India Pvt. Ltd, Indian Immunological Ltd, Intervet International B.V, Kareo Inc, Merck and Co.Inc, Novartis AG, NXGN Management LLC, Pfizer Inc, Santa Cruz Biotechnology Inc, Virbac Group, Zoetis Inc.
Polaris Market Research has segmented the animal biotechnology market report based on animal type, product type, application, end-use, and region:
Animal Biotechnology, Animal Type Outlook (Revenue - USD Billion, 2018 - 2030)
Companion
Dogs
Horses
Cats
Others
Livestock
Poultry
Swine
Cattle
Fish
Sheep /Goats
Others
Animal Biotechnology, Product Type Outlook (Revenue - USD Billion, 2018 - 2030)
Drugs
Diagnostic Test
Vaccination
Feed additives
Reproductive and Genetic
Animal Biotechnology, Application Outlook (Revenue - USD Billion, 2018 - 2030)
Food Safety & Drug Development
Preventive Care of Animals
Treatment of Animal Diseases
Diagnosis of Animal Diseases
Others
Animal Biotechnology, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)
Veterinary Hospitals and clinics
Point of Care testing or In-House Testing
Laboratories
Others
Animal Biotechnology, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Animal Biotechnology Market Insights
- 4.1. Behavioral and Mental Health Software - Industry Snapshot
- 4.2. Behavioral and Mental Health Software Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing R&D Activities by Major Market Players
- 4.2.1.2. Growing Focus Towards Cloning & Transgenic Animals
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Ethical Issues Associated with Animal Biotechnology Products
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Behavioral and Mental Health Software Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Animal Biotechnology Market, by Animal Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Animal Biotechnology Market, by Animal Type, 2018 - 2030 (USD Billion)
- 5.3. Companion
- 5.3.1. Animal Biotechnology Market, by Companion, by Region, 2018 - 2030 (USD Billion)
- 5.3.2. Dogs
- 5.3.2.1. Animal Biotechnology Market, by Dogs, by Region, 2018 - 2030 (USD Billion)
- 5.3.3. Horses
- 5.3.3.1. Animal Biotechnology Market, by Horses, by Region, 2018 - 2030 (USD Billion)
- 5.3.4. Cats
- 5.3.4.1. Animal Biotechnology Market, by Cats, by Region, 2018 - 2030 (USD Billion)
- 5.3.5. Others
- 5.3.5.1. Animal Biotechnology Market, by Others, by Region, 2018 - 2030 (USD Billion)
- 5.4. Livestock
- 5.4.1. Animal Biotechnology Market, by Livestock, by Region, 2018 - 2030 (USD Billion)
- 5.4.2. Poultry
- 5.4.2.1. Animal Biotechnology Market, by Poultry, by Region, 2018 - 2030 (USD Billion)
- 5.4.3. Swine
- 5.4.3.1. Animal Biotechnology Market, by Swine, by Region, 2018 - 2030 (USD Billion)
- 5.4.4. Cattle
- 5.4.4.1. Animal Biotechnology Market, by Cattle, by Region, 2018 - 2030 (USD Billion)
- 5.4.5. Fish
- 5.4.5.1. Animal Biotechnology Market, by Fish, by Region, 2018 - 2030 (USD Billion)
- 5.4.6. Sheep/Goats
- 5.4.6.1. Animal Biotechnology Market, by Sheep/Goats, by Region, 2018 - 2030 (USD Billion)
- 5.4.7. Others
- 5.4.7.1. Animal Biotechnology Market, by Others, by Region, 2018 - 2030 (USD Billion)
6. Animal Biotechnology Market, by Product Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Animal Biotechnology Market, by Product Type, 2018 - 2030 (USD Billion)
- 6.3. Drugs
- 6.3.1. Animal Biotechnology Market, by Drugs, by Region, 2018 - 2030 (USD Billion)
- 6.4. Diagnostic Test
- 6.4.1. Animal Biotechnology Market, by Diagnostic Test, by Region, 2018 - 2030 (USD Billion)
- 6.5. Vaccinations
- 6.5.1. Animal Biotechnology Market, by Vaccinations, by Region, 2018 - 2030 (USD Billion)
- 6.6. Feed Additives
- 6.6.1. Animal Biotechnology Market, by Feed Additives, by Region, 2018 - 2030 (USD Billion)
- 6.7. Reproductive and Genetic
- 6.7.1. Animal Biotechnology Market, by Reproductive and Genetic, by Region, 2018 - 2030 (USD Billion)
7. Animal Biotechnology Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Animal Biotechnology Market, by Application, 2018 - 2030 (USD Billion)
- 7.3. Food safety & Drug Development
- 7.3.1. Animal Biotechnology Market, by Food safety & Drug Development, by Region, 2018 - 2030 (USD Billion)
- 7.4. Preventive care of Animals
- 7.4.1. Animal Biotechnology Market, by Preventive care of Animals, by Region, 2018 - 2030 (USD Billion)
- 7.5. Treatment of Animal Diseases
- 7.5.1. Animal Biotechnology Market, by Treatment of Animal Diseases, by Region, 2018 - 2030 (USD Billion)
- 7.6. Diagnosis of Animal Diseases
- 7.6.1. Animal Biotechnology Market, by Diagnosis of Animal Diseases, by Region, 2018 - 2030 (USD Billion)
- 7.7. Others
- 7.7.1. Animal Biotechnology Market, by Others, by Region, 2018 - 2030 (USD Billion)
8. Animal Biotechnology Market, by End-Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Animal Biotechnology Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.3. Veterinary Hospitals and clinics
- 8.3.1. Animal Biotechnology Market, by Veterinary Hospitals and clinics, by Region, 2018 - 2030 (USD Billion)
- 8.4. Point of care testing or In- House Testing
- 8.4.1. Animal Biotechnology Market, by Point of care testing or In- House Testing, by Region, 2018 - 2030 (USD Billion)
- 8.5. Laboratories
- 8.5.1. Animal Biotechnology Market, by Laboratories, by Region, 2018 - 2030 (USD Billion)
- 8.6. Others
- 8.6.1. Animal Biotechnology Market, by Others, by Region, 2018 - 2030 (USD Billion)
9. Animal Biotechnology Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Behavioral and Mental Health Software Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 9.3. Behavioral and Mental Health Software Market - North America
- 9.3.1. North America: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.3.2. North America: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.3.3. North America: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.3.4. North America: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.3.5. Behavioral and Mental Health Software Market - U.S.
- 9.3.5.1. U.S.: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.3.5.2. U.S.: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.3.5.3. U.S.: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.3.5.4. U.S.: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.3.6. Behavioral and Mental Health Software Market - Canada
- 9.3.6.1. Canada: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.3.6.2. Canada: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.3.6.3. Canada: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.3.6.4. Canada: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.4. Behavioral and Mental Health Software Market - Europe
- 9.4.1. Europe: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.4.2. Europe: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.3. Europe: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.4.4. Europe: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.5. Behavioral and Mental Health Software Market - UK
- 9.4.5.1. UK: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.4.5.2. UK: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.5.3. UK: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.4.5.4. UK: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.6. Behavioral and Mental Health Software Market - France
- 9.4.6.1. France: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.4.6.2. France: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.6.3. France: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.4.6.4. France: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.7. Behavioral and Mental Health Software Market - Germany
- 9.4.7.1. Germany: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.4.7.2. Germany: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.7.3. Germany: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.4.7.4. Germany: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.8. Behavioral and Mental Health Software Market - Italy
- 9.4.8.1. Italy: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.4.8.2. Italy: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.8.3. Italy: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.4.8.4. Italy: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.9. Behavioral and Mental Health Software Market - Spain
- 9.4.9.1. Spain: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.4.9.2. Spain: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.9.3. Spain: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.4.9.4. Spain: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.10. Behavioral and Mental Health Software Market - Netherlands
- 9.4.10.1. Netherlands: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.4.10.2. Netherlands: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.10.3. Netherlands: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.4.10.4. Netherlands: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.4.11. Behavioral and Mental Health Software Market - Russia
- 9.4.11.1. Russia: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.4.11.2. Russia.: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.11.3. Russia: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.4.11.4. Russia: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.5. Behavioral and Mental Health Software Market - Asia Pacific
- 9.5.1. Asia Pacific: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.5.2. Asia Pacific: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.3. Asia Pacific: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.5.4. Asia Pacific: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.5. Behavioral and Mental Health Software Market - China
- 9.5.5.1. China: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.5.5.2. China.: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.5.3. China: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.5.5.4. China: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.6. Behavioral and Mental Health Software Market - India
- 9.5.6.1. India: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.5.6.2. India.: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.6.3. India: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.5.6.4. India: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.7. Behavioral and Mental Health Software Market - Japan
- 9.5.7.1. Japan: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.5.7.2. Japan.: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.7.3. Japan: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.5.7.4. Japan: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.8. Behavioral and Mental Health Software Market - Malaysia
- 9.5.8.1. Malaysia: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.5.8.2. Malaysia.: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.8.3. Malaysia: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.5.8.4. Malaysia: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.9. Behavioral and Mental Health Software Market - Indonesia
- 9.5.9.1. Indonesia: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.5.9.2. Indonesia.: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.9.3. Indonesia: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.5.9.4. Indonesia: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.5.10. Behavioral and Mental Health Software Market - South Korea
- 9.5.10.1. South Korea: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.5.10.2. South Korea.: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.10.3. South Korea: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.5.10.4. South Korea: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.6. Behavioral and Mental Health Software Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.6.2. Middle East & Africa: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.6.3. Middle East & Africa: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.6.4. Middle East & Africa: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.5. Behavioral and Mental Health Software Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.6.5.2. Saudi Arabia: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.6.5.3. Saudi Arabia: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.6.5.4. Saudi Arabia: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.6. Behavioral and Mental Health Software Market - South Africa
- 9.6.6.1. South Africa: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.6.6.2. South Africa: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.6.6.3. South Africa: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.6.6.4. South Africa: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.7. Behavioral and Mental Health Software Market - Israel
- 9.6.7.1. Israel: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.6.7.2. Israel: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.6.7.3. Israel: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.6.7.4. Israel: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.6.8. Behavioral and Mental Health Software Market - UAE
- 9.6.8.1. UAE: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.6.8.2. UAE: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.6.8.3. UAE: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.6.8.4. UAE: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.7. Behavioral and Mental Health Software Market - Latin America
- 9.7.1. Latin America: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.7.2. Latin America: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.7.3. Latin America: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.7.4. Latin America: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.7.5. Behavioral and Mental Health Software Market - Mexico
- 9.7.5.1. Mexico: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.7.5.2. Mexico: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.7.5.3. Mexico: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.7.5.4. Mexico: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.7.6. Behavioral and Mental Health Software Market - Brazil
- 9.7.6.1. Brazil: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.7.6.2. Brazil: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.7.6.3. Brazil: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.7.6.4. Brazil: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
- 9.7.7. Behavioral and Mental Health Software Market - Argentina
- 9.7.7.1. Argentina: Behavioral and Mental Health Software Market, by Animal Type, 2018 - 2030 (USD Billion)
- 9.7.7.2. Argentina: Behavioral and Mental Health Software Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.7.7.3. Argentina: Behavioral and Mental Health Software Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.7.7.4. Argentina: Behavioral and Mental Health Software Market, by Application, 2018 - 2030 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Bayer AG
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Boehringer Ingelheim International GmbH
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Biogenesis Bago
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Ceva
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. CSL Limited
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Elanco
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Heska Corporation
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Hester Biosciences Limited
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Idexx Laboratories
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Vet India Pvt. Ltd
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Indian Immunological Ltd
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Intervet International BV
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Kareo Inc
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Merck and Co.Inc
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Novartis AG
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
- 11.16. NXGN Management LLC
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development
- 11.17. Pfizer Inc
- 11.17.1. Company Overview
- 11.17.2. Financial Performance
- 11.17.3. Product Benchmarking
- 11.17.4. Recent Development
- 11.18. Santa Cruz Biotechnology Inc
- 11.18.1. Company Overview
- 11.18.2. Financial Performance
- 11.18.3. Product Benchmarking
- 11.18.4. Recent Development
- 11.19. Virbac Group
- 11.19.1. Company Overview
- 11.19.2. Financial Performance
- 11.19.3. Product Benchmarking
- 11.19.4. Recent Development
- 11.20. Zoetis Inc.
- 11.20.1. Company Overview
- 11.20.2. Financial Performance
- 11.20.3. Product Benchmarking
- 11.20.4. Recent Development